Ricebran Technologies Aktie

mit ihren klugen Beiträgen also in meinen Augen alle Korrupt und kommen immer wieder mit ihren Betrügereien hier durch .....nun zum Glück bin ich dieses mal nicht betroffen (war es aber des öfteren in der vergangenheit) aber mal ernsthaft wenn ein analyst nach einem kursanstieg von 0,30€ auf 3,7€ von irgendwas wie ruhig abwarten oder gewinne laufen lassen faselt ist der doch nur bedingt zurechnungsfähig oder sehe ich da was falsch ???????????? lg conny

knapp 60 Prozent minus seit erstem Posting... : ( Heute gibts es wieder Quartalszahlen und ich bin super gespannt. Die Erwartungen dürften nicht alzu hoch sein, mal sehen. Wenn die Zahlen schlecht ausfallen, dann gute Nacht. Dann erwarte ich den Kurs noch einmal 50% tiefer. Wenn sie besser als erwartet ausfallen (schön wären 2-3 cent je Aktie), dann sollten wir die Korrektur endlich beendet haben. Komm schon, zieh! : ) Gruß Bow

Nach den herben Kursrückgängen, die aufgrund der hohen Erwartungen und dann nicht erfüllten Quartalsergebnisse Berechtigung hatten, finden wir uns in meinen Augen an einem interessanten Punkt wieder. Mit einem Kursrückgang seit dem Hoch von 5,-$ auf 1,40$ ist auch die Bewertung auf nun etwa 150 Mio US-Dollar zurückgefallen. Damit sehen die Kennzahlen nach Konsensschätzungen bei Yahoo(allerdings nur 2 Analysten) folgendermaßen aus: KUV bei etwa 2, KGV bei etwa 10 auf Basis der geschätzten Unternehmenszahlen für 2008. Ich werde meine Position zu diesem Zeitpunkt etwas aufstocken. Nun hier die News von heute: NutraCea Announces Expansion of Baby Cereal Business With Orders for International and Domestic Retail Chains Receives Orders from Rafferty's Garden in Australia and a New National Brand in the U.S. PHOENIX, Sept. 13 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a leader in stabilized rice bran (SRB) nutrient research and technology, announced today its baby cereal business is expanding with the addition of two new customers; Rafferty's Garden in Australia and a new national brand that will be launched into major and specialty retail chains in the fourth quarter of 2007. "We are extremely delighted to have two new customers for our baby cereal. Our baby cereal business is increasing significantly and we've added various line extensions to our existing product line up including multi-grain cereals, fruit-flavored cereals and DHA-fortified cereals that give customers more choices," said Margie Adelman, Senior Vice President of NutraCea. Rafferty's Garden baby cereal will be sold throughout Australia and the new national brand will be available at major baby specialty retail chains, national chain supermarkets and the largest natural food grocery store chain in the U.S.," added Adelman. "We've collaborated closely with NutraCea to develop an innovative range of premium baby food cereals and are set to implement a very substantial baby food launch in the Australian supermarkets. The products will be available in Australia's major supermarkets: Coles, BiLo, Woolworths, and Safeway and we're quite confident they will be successful in this category, thanks to the integral involvement of NutraCea," stated Adrian Pike, Chairman of Rafferty's Garden. "We are very proud of our baby cereal product line, which we believe is superior in quality to many national brands that are currently available. This coincides with our business plans to build a value-added plant in the Phoenix area, which will include various packaging options and will allow us to offer customized solutions for any future customers in this rapidly expanding food segment," said Leo Gingras, Chief Operating Officer. Kurs sollte heute mind. 8-10% anziehen! Vielleicht sogar von akt. 1,40 auf 1,60 ... Gruß Bow

NutraCea Announces Record Second Quarter and Six Months Financial Results Company Reports $13 Million Revenue for Q2 PHOENIX, Aug. 14 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a leader in stabilized rice bran ("SRB") nutrient research and technology, announced today its financial results for the second quarter and six months ended June 30, 2007. Total revenues for the second quarter were approximately $13.0 million, an increase of $8.8 million, or 212% from the second quarter fiscal 2006. For the three months ended June 30, 2007, the Company's net profit was $2 million, or $0.01 per diluted share, compared to a net profit of $399,000, or $0.00 per diluted share, in the same period last year. For the six months ended June 30, 2007, the Company's net profit was $1.8 million, or $0.01 per diluted share compared to a net profit of $166,000, or $0.00 per diluted share for the six months ended June 30, 2006. Gross margin from product sales in the second quarter was $4.1 million, or 52%, compared to $1.8 million, or 44%, during the second quarter of last year. Gross margin from product sales for the six months was $5.0 million, or 50%, compared to $3.5 million or 44% during the six months of the previous year. For the six months ended June 30, 2007, consolidated revenues were approximately $15 million, an increase of approximately $7 million, or 89% compared to the comparable six months of the previous year. Chief Executive Officer Mr. Bradley Edson stated, "NutraCea has delivered a solid quarter of sales growth and new initiatives. During the quarter several new products were launched with our stabilized rice bran as a primary ingredient and we expect more product launches from major food companies going forward and to experience progress in all channels of distribution. We have expanded our production capacity and we intend to continue to do so both domestically and internationally. In the past year we have increased our capacity from less that ten thousand tons annually to over 40,000 with expectations of reaching 80,000 tons during first quarter of 2008. The estimated global demand still far exceeds our current production capacity and we will endeavor to meet that demand as quickly as possible." Mr. Leo Gingras, COO of NutraCea noted, "Our expansion in the U.S. continues at an aggressive pace with completion of our Mermentau, LA and Arbuckle, CA plants, completion of our expansion at Dillon, MT and the acquisition of assets in Freeport, TX. Construction of our Lake Charles, LA, facility, although delayed by weather, should be completed in the first quarter of 2008. We are particularly pleased that our international expansion plans have taken a large step forward with the formation of our joint venture in Southeast Asia, a region that produces more than ten times as much rice bran as the U.S. and E.U combined. We are also moving ahead on our first European facility and look forward to servicing our customers in the E.U. with local production in 2008. Edson concluded, "We see diverse markets for stabilized rice bran and have taken appropriate steps to increase demand, develop marketing channels and increase production capacity. We have a proprietary product which has unique nutritional benefits, and, to date, we are the only company that can lay claim to the process that can stabilize rice bran with a shelf life of over one year without diminishing its superior nutrient profile. The balance sheet continues to remain strong with $51.5 million in cash and cash equivalents and no debt. We look forward to successfully capitalizing on the opportunities that lay ahead." NutraCea will be hosting a conference call on Wednesday, August 15, 2007 at 11:30 AM EDT with the investment community, featuring Brad Edson, Chief Executive Officer and President of NutraCea. Interested parties may participate in the call by dialing 877-407-8037; international callers dial 201-689-8037. In addition, the conference call will be available via a webcast that can be accessed at: http://www.vcall.com/IC/CEPage.asp?ID=119950 and will be archived for 30 days. (Tables to Follow) NUTRACEA AND SUBSIDIARIES CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited) Six Six Three Three Months Months Months Months Ended Ended Ended Ended June 30, June 30, June 30, June 30, 2007 2006 2007 2006 Revenues: Net product sales $9,983,000 $7,932,000 $7,996,000 $ 4,159,000 Royalty and licensing fees 5,010,000 16,000 5,000,000 7,000 Total revenue 14,993,000 7,948,000 12,996,000 4,166,000 Cost of goods sold 4,976,000 4,433,000 3,863,000 2,333,000 Gross margin 10,017,000 3,515,000 9,133,000 1,833,000 Research and development expenses 291,000 198,000 170,000 94,000 Selling, general and administrative expenses 7,970,000 2,852,000 5,657,000 1,348,000 Professional fees 1,995,000 434,000 1,536,000 101,000 Total operating expenses 10,256,000 3,484,000 7,363,000 1,543,000 Income (loss) from operations (239,000) 31,000 1,770,000 290,000 Other income (expense) Interest income (net) 1,388,000 135,000 876,000 109,000 Gain on settlement 1,250,000 - - - Loss on retirement of assets (309,000) - (309,000) - Loss on equity investment (250,000) - (250,000) - Total income before income tax 1,840,000 166,000 2,087,000 109,000 Income tax expense (85,000) - (85,000) - Net income $1,755,000 $166,000 $2,002,000 $399,000 Basic and diluted earnings per share: Basic income per share $0.01 $0.00 $0.01 $0.00 Fully diluted income per share $0.01 $0.00 $0.01 $0.00 Weighted average basic number of shares outstanding 118,952,000 68,808,000 136,257,000 71,729,000 Weighted average diluted number of shares outstanding 148,954,000 119,309,000 167,259,000 123,293,000 NUTRACEA AND SUBSIDIARIES CONSOLIDATED CONDENSED BALANCE SHEETS June 30, 2007 Dec. 31, 2006 (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 51,500,000 $14,867,000 Restricted cash 545,000 - Marketable securities 459,000 368,000 Trade accounts receivable, net of allowance for doubtful accounts of $1,075,000 and $20,000, respectively 8,075,000 7,093,000 Inventories 801,000 796,000 Notes receivable, net of discount, current portion 4,274,000 1,694,000 Deposits and other current assets 1,767,000 1,383,000 Total current assets 67,421,000 26,201,000 Notes receivable, net of current portion 5,216,000 682,000 Property and equipment, net 14,673,000 8,961,000 Investment in joint venture 1,250,000 - Other intangible assets, net 5,616,000 5,097,000 Goodwill 39,372,000 32,314,000 Other non-current assets 12,000 - Total assets $133,560,000 $73,255,000 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable and accrued liabilities $4,866,000 $2,778,000 Accrual for contribution to related party joint venture 1,500,000 Deferred revenue 29,000 103,000 Total current liabilities 6,395,000 2,881,000 Commitments and contingencies Convertible, series B preferred stock, no par value, $1,000 stated value, 20,000,000 shares authorized, 0 and 470 shares issued and outstanding - 439,000 Convertible, series C preferred stock, no par value, $1,000 stated value, 25,000 shares authorized, 2 and 5,468 shares issued and outstanding 2,000 5,051,000 Shareholders' equity: Common stock, no par value 350,000,000 shares authorized, 140,217,953 and 103,977,715 shares issued and outstanding in 2007 and 2006, respectively 174,544,000 114,111,000 Accumulated deficit (47,550,000) (49,305,000) Accumulated other comprehensive income, unrealized gain on marketable securities 169,000 78,000 Total shareholders' equity 127,163,000 64,884,000 Total liabilities and shareholders' equity $133,560,000 $73,255,000 About NutraCea NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through its wholly owned subsidiary RiceX, the company manufacturers as well as distributes products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual properties to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health- promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the company's filings with the SEC and you can visit the NutraCea web site http://www.NutraCea.com. Forward Looking Statements This release contains forward-looking statements, including, but not limited to, statements regarding revenue recognition, the timing for completion of our facilities, our ability to advance international initiatives, and our anticipated sales and production capacity. Actual results may differ from those projected due to a number of risks and uncertainties, including, but not limited to the possibility that any increased production capacity will be delayed or reduced in whole or in part, market demand for our products does not remain strong, future customers are unable to timely pay for our products, and by all other matters specified in the Company's filings with the Securities and Exchange Commission. These statements are made based upon current expectations that are subject to risk and uncertainty. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report. Company Contact: Investor Relations Contact: Margie Adelman Stephen D. Axelrod, CFA Senior V.P. NutraCea Wolfe Axelrod Weinberger Assoc, LLC 916-933-7000 Ext. 646 212-370-4500 916-220-3500 cell steve@wolfeaxelrod.commadelman@nutracea.com Media Relations Contact: Alisa D. Steinberg Wolfe Axelrod Weinberger Assoc, LLC 212-370-4500 alisa@wolfeaxelrod.com SOURCE NutraCea gruß Bow